Evaluating Teladoc Health: Insights From 14 Financial Analysts
Portfolio Pulse from Benzinga Insights
Teladoc Health (NYSE:TDOC) has received mixed analyst ratings, with a recent downward trend in price targets. Analysts have adjusted their ratings and price targets, reflecting changing market conditions and company performance. Teladoc faces financial challenges, including declining revenue, negative net margin, and high debt-to-equity ratio.
September 17, 2024 | 8:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Teladoc Health has received mixed analyst ratings, with a recent downward trend in price targets. Analysts have adjusted their ratings and price targets, reflecting changing market conditions and company performance. Teladoc faces financial challenges, including declining revenue, negative net margin, and high debt-to-equity ratio.
The article highlights a downward trend in analyst price targets for Teladoc Health, indicating a negative sentiment. The company's financial challenges, such as declining revenue and high debt, further support a likely negative short-term impact on the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100